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doi:10.1016/j.ejvs.2011.02.020Abstract Purpose: Evaluate the results of the two modalities used for the treatment of
Secondary Aorto-Enteric Fistula (SAEF): In situ Reconstruction (ISR) and Extra-Anatomic Recon-
struction (EAR). The primary endpoints of this study were early standard 30-day mortality and
reinfection (RI). Secondary endpoints were perioperative morbidity, late mortality, primary
graft patency, and major amputation rates.
Material & method: Diagnosis of SAEF was based on clinical examination and the results of pre-
operative duplex or CT scans. Surgical management was performed according to local protocols
at the participating institutions:
e Elective surgery: ISR or staged EAR
e Emergency surgery: aortic clamping followed by ISR or EAR
e Selected high-risk patients: endovascular repair.
Statistical analyses were performed using the actuarial method. Univariate analysis was
used for analysis of categorical variables, and multivariate analysis was performed with
a Cox proportional hazard regression.
Results: A total of 37 patients were included in this retrospective multicentre study. Mean
follow-up was 41 months. The majority of the patients (20, 54%) presented acutely. EAR was
performed in 9 patients (24%), ISR in 25 (68%), and 3 patients underwent endovascular repair.f Nice Sophia-Antipolis, Department of Vascular Surgery, 8 rue Pierre Devoluy, 06000 Alpes Maritimes,
3 492032943.
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Results of Secondary Aortoenteric Fistulae 749Bacteriological cultures were negative in 3 patients (9%). The most frequent organisms identi-
fied were Candida species and Escherichia coli.
The 30-day mortality was 43% (16 patients). Patient age (>75 years) was the sole predictive
factor associated with operative mortality (pZ 0.02); pre-operative shock was not statistically
significant (pZ 0.08). There were 2 graft thromboses and 1 femoral amputation. Primary graft
patency was respectively 89% at 1 year and 86% at 5 years; limb salvage rates were 100% at 1
and 5 years and 86% at 6 years, with no difference between ISR and EAR. RI occurred after
9.3  13 months in 8 of 17 surviving patients and was fatal in all cases. For all surviving
patients, the RI rate at 1 and 2 years was 24% and 41% respectively. There was no significant
difference in the rate of RI after ISR or EAR.
Conclusion: EAR does not appear to be superior to ISR. The risk of RI increased with the length
of follow-up, irrespective of the treatment modality. Life-long surveillance is mandatory. Our
results with endovascular sealing of SAEF should be considered a bridge to open repair.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Secondary aorto-enteric fistula (SAEF) is one of the possible
presentations of aortic graft infection (AGI). The incidenceof
AGI over the past three decades has been reported at
0.6e3%,1,2 and SAEF accounts for 20e45% of AGI. The true
incidence is certainly higher3 because of patients lost to
follow-up, insufficient follow-up or lack of information about
late infection. Despite numerous reports in the literature,
the optimal management of SAEF remains ambiguous.4,5
Traditional treatment consists in staged or simultaneous
extra-anatomic revascularisation (EAR) of the lower limb
with suture of the bowel lesion and prosthetic aortic graft
excision. However, an increasing number of patients undergo
in situ reconstruction (ISR) using various conduits, following
the lead of the University Texas-Houston.6 These treatment
alternatives are difficult to compare because the number of
patients presenting with SAEF is fortunately low. In addition,
to confound comparison, SAEF data have often been mixed
with AGI data, and the studies published have extended over
two decades, with the consequence of changes in optimal
treatment. Finally, results of the various treatment options
are rarely reported in the same series of patients, and follow-
up is often suboptimal.
This contemporary study was conducted over 8 years and
includes late follow-up data allowing evaluation of the
clinically significant factors influencing the results of the
two modalities used to manage SAEF.
Patients and Methods
From January 2000 to June 2008, all patients admitted for
SAEF were included in this retrospective multicentre study.
Six university hospitals participated in this study following
the approval of their local ethic committee. The diagnosis
of SAEF was based on clinical examination: gastrointestinal
(GI) bleeding, groin mass or sinus, graft thrombosis, the
results of pre-operative scintigraphy, duplex or computed
tomography (CT) scans detecting perigraft fluid, with or
without an air interface, pseudo-aneurysms and graft
thrombosis. Evaluation of sepsis was based on clinical
factors (fever, leucocytosis, bacteriaemia or hypotension)
and presence of a retroperitoneal abscess on CT scans.
Preoperative conventional angiography was performed only
when clinically appropriate. Specimens for microbiological
culture, including specimens of any external discharges,blood culture in case of bacteriaemia and ultrasound (US)-
or CT-guided puncture in case of retroperitoneal abscess
were obtained prior to surgery whenever possible so that
appropriate antibiotic therapy could be initiated prior to
surgery. In the absence of a specimen for analysis, broad-
spectrum antibiotics and antifungal treatment, including
coverage of enteric flora, were administered. Oral antibi-
otics were continued for at least 6e8 weeks, according to
the protocols of each participating centre and depending
on the virulence of the specific organisms cultured.
The surgical management of patients with SAEF
complied with local protocols at the participating institu-
tions. In general, this consisted of:
- elective surgery with or without clinical sepsis or
abscess on CT:
B ISR or staged EAR (before aortic graft excision);
- emergency surgery with shock:
B aortic clamping followed by followed by ISR or EAR;
- Selected high-risk patients:
B endovascular repair was performed.Total graft excision was the rule when infection involved
the entire prosthesis. Partial graft excision was performed
only when infection was limited to the graft body or to
a single limb, provided the remainder of the graft was well
encapsulated.
During surgery, additional specimens were taken for
bacteriological analysis, and all excised prosthetic grafts
were sent for culture. All patients underwent complete
debridement of surrounding tissues followed by irrigation of
the operative field with liberal amounts of standard povi-
doneeiodine and/or antibiotic solution. For ISR, the
conduits used in this study were limited to cryopreserved
allografts, autogenous veins, Rifampin-bonded prostheses
(Gelseal, Vascutek, Renfrewshire, Scotland, UK) and silver-
coated prostheses (Inter Gard Silver prosthesis (IGS); Inter
Vascular, La Ciotat, France). The decision was based on
local availability, and the discretion of responsible surgeon.
The aortic stump suture and the grafts for ISR were covered
with an omental flap, whenever possible.
Serial CT scans of the aortic stump suture or the in situ
graft were obtained before discharge from the hospital, at
3 and 6 months post surgery and biannually thereafter.
Table 1 Clinical presentation in 37 patients with
secondary aorto-enteric fistula.
SYMPTOMS N %
Sepsis (fever, leukocytosis,
bacteremia, hypotension)
15 41
Gastrointestinal bleeding
ewithout shock 17 46
ewith shock 10 27
Abdominal or back pain 8 22
Graft limb thrombosis 5 14
Groin fistula 4 11
Peripheral abscess 3 8
Femoral false aneurysm 2 5
Peritonitis 2 5
19 patients had 1 clinical presentation; 18 patients had >1
clinical presentation.
750 M. Batt et al.The primary end point of this study was 30-day
mortality. However, because some patients died as a result
of the intervention later on during the course of hospital-
isation, we also assessed procedure-related mortality,
regardless of the post-operative time span and reinfection
(RI). Secondary end points were perioperative morbidity,
late mortality, primary graft patency and major amputation
rates.
Statistical analyses were performed on an ‘intention-to-
treat’ basis. Freedom from RI and survival rates were
estimated by the actuarial method; differences were
determined by the log-rank test. Univariate analysis was
used for categorical variables using Pearson’s chi-square or
Fischer’s exact test. Differences between means were
tested with Student’s t-test. A p value of <0.05 was used to
determine statistical significance. Multivariate analysis was
performed using a Cox proportional hazard regression. All
analyses were performed using STAT VIEW software (SAS
Institute, Inc. 1992e1998; version 5.0).
Results
Study population
Among the 4137 patients operated upon between 2000 and
2008 at the six university hospitals participating in this
retrospective study, 82 AGIs occurred. SAEF was identified
in 37 of these patients (45%), who were all included in this
retrospective study. Follow-up data for all surviving
patients were available up to June 2008. Mean  standard
deviation (SD) follow-up was 41  39 months (range 3e101
months).
Presentation
The all-male group of 37 SAEF patients had a mean  SD age
of 72  9 years (range 48e86 years). Present or past ciga-
rette smokers accounted for 28 of the 37 patients (77%),
with a mean of 51  26 pack-years. Other pertinent risk
factors included coronary artery disease in 21 (57%),
hypertension in 19 (51%), chronic obstructive pulmonary
disease in eight (23%), hyperlipidaemia in seven (19%),
renal failure (defined as creatinine concentration
>3.0 mg dl1) in three (37%) patients, and risk factors for
infection in nine (24%), diabetes mellitus in five (14%),
malnutrition in two (5%), malignancy in two (5%) and steroid
therapy in one (3%). Certain patients had more than one
pertinent risk factor. The initial indication for aortic
reconstruction was aneurysmal in 18 patients (49%) and
occlusive in 19 patients (51%). An aortobifemoral bypass
was the most commonly used configuration (n Z 19), fol-
lowed by aorto-bi-iliac bypass and aortic tube grafts in 11
and seven patients, respectively. All repairs were per-
formed with polyester grafts (nZ 36); the single exception
was a polytetrafluoroethylene (PTFE) conduit. During the
initial procedures, closing of the retroperitoneal space, and
graft inclusion in the remaining aneurysm sac were
routinely used. The omentum was used when the
duodenum was in contact with the graft. Specimens of
thrombus or aneurysm wall were routinely sent for micro-
biology examination and no infected abdominal aorticaneurysm (AAA) was identified. Two of the initial proce-
dures for aneurysms were performed emergently for
rupture; the remaining aortic reconstructions were elective
procedures. Three patients in the elective group had graft-
related complications after their original surgery, which
required additional surgery for graft limb thrombosis
(n Z 1) or groin wound complications (n Z 2).
Clinical symptoms at presentation with SAEF are shown
in Table 1. The mean  SD interval between initial pros-
thetic graft insertion and development of clinical symptoms
related to SAEF was 59  41 months (range 3e347 months).
Of the 27 patients presenting with gastrointestinal (GI)
bleeding, 14 (51%) experienced an initial ‘herald’ bleed
that prompted admission to hospital, whereas 13 patients
reported multiple recurrent bleeding episodes. GI bleeding
(melena or haematemesis) occurred over a mean  SD
interval of 9  6 days (range 4 he11 months) before
admission of the patient to the hospital. Other symptoms
occurred over a mean  SD interval of 3  1.5 month (range
3 dayse48 months), indicating a relative diagnostic delay.
The majority (20, 54%) of our patients presented acutely:
shock 13 (35%): 10 haemorrhagic, three septic, five (14%)
acute lower limb ischaemia and two (5%) peritonitis.
Endoscopic evaluation of GI bleeding was common.
Esophagoduodenoscopy (EGD) was performed for 27
patients (73%) and colonoscopy for 19 (51%). EGD was
diagnostic in 15 cases (56%): exposed aortic prosthetic graft
two (7%), fresh adherent mucosal clot one (4%) and active
bleeding from D3 12 (45%).
Imaging studies. Radionuclide imaging studies were used
infrequently, as in two (5%) patients. Abdominal/pelvic CT
scans were performed in all 37 patients. CT findings were:
perigraft fluid (with and without an air/fluid interface) 14
(38%) in each group, proximal false anastomotic aneurysm
17 (46%), retroperitoneal abscess two (5%), and graft
thrombosis five (14%). Overall, 31 (84%) of the 37 patients
demonstrated CT abnormalities consistent with the pres-
ence of SAEF. Three of the remaining patients (8%) pre-
sented with subtle abnormalities, with loss of
retroperitoneal soft tissue between the proximal aortic
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a normal, non-diagnostic CT examination requiring trans-
abdominal exploration.Management
Elective surgery was performed for 17 patients (46%); 15
required ISR or staged EAR and two required endovascular
repair. An emergent procedure was performed for 20
patients (54%): 19 required ISR or EAR and the last was
managed by endovascular repair.
Total and partial graft excisions were performed for
respectively 27 (73%) and seven patients (19%). The
remaining three patients (8%), who underwent endovascular
treatment, did not require graft excision. At exploration,
graft communication with the distal duodenum was found in
30 patients (88%), associated with a proximal jejunal fistula
in two patients, with the ileum (one patient) and with the
right (one patient) and left colon (two patient). Duodenal
defects were treated by duodenorraphy in 27 patients (79%),
associated in two cases with gastrojejunostomy. Segmental
duodenal resection with end-to-end anastomosis was
required for the threeotherpatients due to severedamage to
the duodenal wall associated with gastrojejunostomy. Small
bowel defects were repaired by handsewn re-anastomosis.
Resection and proximal diversion were required in all three
cases of colonic involvement. Bowel communication
involved the proximal anastomosis in 25 patients (74%) and
was limited to the graft body or limb in nine patients (26%).
EAR was performed in nine patients (24%) by axillofe-
moral and cross-femoral PTFE in seven patients and by bi-
axillo-femoral PTFE in two patients. In the majority of
patients (eight), simultaneous repairs were sequenced with
EAR that was performed first to minimise lower limb and
pelvic ischaemia (n Z 5). Graft excision and bowel repair
were performed first (n Z 3), followed by EAR in patients
with haemorrhagic shock (n Z 2) or hypotension with
uncontrolled sepsis (n Z 1). Staged EAR followed by graft
excision 2 days later was possible in one haemodynamically
stable patient.
ISR after aortic graft excision was performed in 25
patients (68%): silver-coated prosthesis (IGS) in 13 patients
(52%), cryopreserved allograft in eight (32%), a Rifampin-
bonded prosthesis in three (12%) and an autogenous vein in
one patient (4%). Graft excision and ISR were performed
emergently in 12 patients (48%) (seven for bleeding shock,
two for septic hypotension and three for graft-limb
thrombosis with lower limb ischaemia) and electively in 13
patients (52%). Of these 25 patients (68%) who underwent
ISR, two required renal artery reimplantation with supra-
renal aortic clamping.
The clinical characteristics, presentation and microbi-
ology were comparable in the 34 patients treated with EAR
and ISR and are summarised in Table 2.
Three patients were managed by endovascular repair
using a Zenith device (Cook Inc., Bloomington, IN, USA):
aorto-uni-iliac with femoroefemoral crossover in two
patients with high co-morbidities and in one patient with
haemodynamic shock.
The mean  SD operative time for EAR, ISR and endo-
vascular repair was respectively 320  120 min (range180e480 min), 280  100 min (range 160e360 min) and
150  30 min (range 110e205 min). The longer operative
time for EAR did not differ in a statistically significant
manner (p Z 0.07) from either of the other modalities.
The mean  SD blood transfusion for GI bleeding was
6  3.5 units of blood (range 1e16) before and during
surgical repair of SAEF.Microbiology
The excised graft was cultured in 33 patients (97%).
Bacteriological cultures were negative in three patients
(9%). The most frequently identified organisms were
Candida sp.; the most frequent bacteria were Escherichia
coli (Table 3). Gram-negative only species were found in 17
patients (52%), Gram-positive only in eight (24%) and both
Gram-positive and Gram-negative in eight patients (24%).
Virulent and non-virulent organisms were present in
respectively 25 (83%) and five (17%) positive bacteriological
cultures. The virulent organisms cultured included Gram-
negative, anaerobic, methicillin-resistant Staphylococcus
and fungal and polymicrobial species, including coagulase-
negative Staphylococcus. Antibiotics were given in accor-
dance with the sensitivity of the bacteria. Without this
information, vancomycin and gentamicin were given intra-
venously together with antifungal treatment. Oral antibi-
otics were continued for at least 6 weeks. No patients
received long-term or indefinite antibiotic therapy.Immediate outcomes
Mortality
The 30-day mortality was 43% (16 patients) and the
procedure-related death rate was 54% (20 patients). The
main cause of death was multi-system organ failure (MSOF)
that occurred for seven patients (35%); post-operative
shock occurred in four patients (20%), after three ISRs
(aortic graft disruption) and one EAR (aortic stump leakage)
(Table 4).
Univariate analysis identified patient age (>75 years) as
being correlated with operative mortality (pZ 0.02) for the
study population as a whole, whereas the differences in pre-
operative shock were not statistically significant (pZ 0.08).
There was no association with ISR or EAR (pZ 0.98), total or
partial excision of the infected graft (p Z 0.43), type of
duodenal/enteral treatment (pZ 0.85), or the presence of
virulent organisms (p Z 0.38) or Candida sp. (p Z 0.86).
Furthermore, there was no association with mortality or any
co-morbidity: coronary artery disease (p Z 0.60), chronic
renal insufficiency (p Z 0.8) or presence of diabetes
(pZ 0.11). Inmultivariate logistic regression analysis, taking
into account factors with a p value 0.10 in univariate
analysis, neither pre-operative shock (odds ratio
(OR)Z 0.107; 95% confidence interval (CI)Z 0.010e1.145;
pZ 0.06) nor diabetes (ORZ 0.073; 95% CIZ 0.004e1.526;
pZ 0.9) were associated with operative mortality. Patient
age (OR Z 0.098; 95% CI Z 0.10e0.928; p Z 0.04) was
confirmed to be the only significant predictor of operative
mortality.
Table 2 Clinical characteristics, presentation, and microbiology in 34 patients with secondary aorto-enteric fistula treated by
axillofemoral or In situ reconstruction.
Type of reconstruction
Axillo-femoral in situ p
n Z 9 % n Z 25 % Value
Demographics:
Mean age (years) 70.2 69.3 1.0
Male gender 9 100 25 100 e
Cardiovascular risk factors:
Smoker 7 78 19 76 1.0
Hypertension 5 56 13 52 0.91
Coronary artery disease 4 44 13 52 0.81
Diabetes mellitus 2 22 3 12 0.06
Chronic renal failure 1 11 2 8 0.93
Chronic pulmonary disease 4 44 8 33 0.08
Clinical presentation:
Sepsis (fever, leukocytosis, bacteremia, hypotension) 3 33 12 48 0.08
Septic shock 1 11 2 8 0.93
Gastrointestinal bleeding:
- without shock 4 44 12 48 0.96
- with shock 2 22 7 28 0.91
Graft limb thrombosis 2 33 3 12 0.058
Type and extent of infection:
Proximal pseudo-aneurysm 3 33 12 48 0.07
Total graft excision 7 77 20 80 0.97
Partial graft excision 1 11 6 24 0.07
Microbiology:
Candida species 3 33 11 44 0.08
Virulent organisms 5 56 17 68 0.82
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The mean  SD hospitalisation was 20  8 days (range 1e90
days). Twenty-two patients (59%) had 29 perioperative
complications, the majority of which were related to theTable 3 Bacteriological findings for patients with
secondary aorto-enteric fistula.
Organism cultured N %
Gram-positive
- Streptococcus viridans 7 21
- Enterococcus 4 12
- Coagulase-negative Staphylococcus 3 9
- Methicillin-resistant Staphylococcus 3 9
Gram-negative
- Escherichia coli 12 36
- Klebsiella 5 15
- Pseudomonas aeruginosa 3 9
- Enterobacter 3 9
Fungus 14 42
Anaerobes 1 3existence of a wound (seven patients, 19%). These included
all patients, who required surgical treatment for a groin
wound, abdominal fascia dehiscence or femoral anasto-
motic rupture caused by incomplete resection of the initial
infected prosthesis. Acute limb ischaemia without limb loss
occurred in three (8%) patients: these femoro-popliteal
(two patients) and limb graft occlusions (one patient) were
successfully managed with a Fogarty catheter.
The most common medical complication was pulmonary
failure requiring ventilator support for an extended period
of time (Table 5). Acute renal failure occurred in three
patients (8%), two of whom required early dialysis.
However, no patient required permanent dialysis. No
difference in morbidity was noted between ISR and EAR.
The sole morbidity, which approached, but did not reach,
statistical significance was colonic ischaemia (p Z 0.056).Long-term outcomes
Graft occlusion e amputation
There were two graft thromboses. One occurred after two
episodes of occlusion, 11 and 14 months after EAR, and
required ISR without amputation. The second occurred 8
Table 4 Details of 20 procedure-related deaths.
Age
(yr)
Presentation ASA Surgical
procedure
Graft microbiology Complications Post operative
day of death
86 GI bleeding 4 ISR (IGS) No growth MSOF 3
82 Shock from GI bleeding 3 ISR (IGS) No growth Hemorrhagic shock 17
57 GI bleeding e peripheral
abscess
3 ISR (IGS) Candida sp, Enterobacter,
Pseudomonas aeruginosa.
Septic shock 4
72 Sepsis 3 ISR (allograft) Candida sp, coagulase-
negative, Staphylococcus,
E. coli.
Hemorrhagic shock 32
71 Shock from GI bleeding 3 ISR (allograft) Not available Acute myocardial
infarction
1
75 Sepsis e peripheral abscess 3 ISR (autologous
vein)
No growth Respiratory sepsis 6
54 Shock from GI bleeding 4 ISR (IGS) Not available Acute lower
limb ischaemia,
renal failure
12
83 Sepsis e GI bleeding 3 ISR (IGS) Klebsiella, Streptococcus,
E. coli, Enterobacter
MSOF 1
70 Sepsis with shock 4 ISR (allograft) Not available Hemorrhagic shock 32
70 Sepsis e Back pain 3 ISR (allograft) Candida sp, Streptococcus,
Enterobacter.
Colonic infarction 20
75 Back pain e groin fistula 3 ISR (Rifampin) Candida sp, Streptococcus. MSOF 2
73 GI bleeding þ graft
thrombosis
3 ISR (Rifampin) E. coli, Klebsiella. Acute lower
limb ischaemia,
renal failure
3
82 Shock from GI bleeding 4 ISR (IGS) Candida sp, Perfringens,
Enterobacter,
Staphylococcus aureus.
MSOF 17
79 Sepsis with shock, acute
respiratory failure
4 ISR (IGS) Not available MSOF 2
81 Femoral false aneurysm 4 EAR (PTFE) Proteus mirabilis,
coagulase-negative
Staphylococcus.
Duodenal leakage 50
76 Shock from GI bleeding 3 EAR (PTFE) Not available MSOF 15
68 Sepsis e Back pain 3 EAR (PTFE) Candida sp, Streptococcus,
Staphylococcus aureus.
Acute myocardial
infarction
0
71 Sepsis with shock 3 EAR (PTFE) Staphylococcus aureus,
E. coli, MRSA
MSOF 2
75 GI bleeding e graft limb
thrombosis
3 EAR (PTFE) Streptococcus Hemorrhagic shock 90
78 Shock from GI bleeding 3 Endoprosthesis Candida sp, E. coli. Myocardial infarction 1
ASA: American Society of Anesthesiology; GI: gastrointestinal; ISR: In situ reconstruction; EAR: extra-anatomic reconstruction; IGS; Inter
Gard Silver; MSOF: multi-system organ failure; PTFE: polytetrafluoroethylene.
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in death.
One femoral amputation was required in a third patient
after occlusion of a femoro-popliteal bypass at 70 months
of follow-up.
Primary graft patency rates were, respectively, 89% at 1
year and 86% at 3 and 5 years; limb salvage rates were 100%
at 1 and 5 years and 86% at 6 years, with no difference
between ISR and EAR.
Recurrence of infection
RI after a mean  SD interval of 9.3  13 months (range
3e24 months) occurred in 8 of 17 surviving patients (47%)and was fatal in all cases. All cases of RI occurred after
duodenal defects treated by duodenorraphy and despite
total resection of the initial infected graft. There were
three cases of RI (27%) in 11 surviving ISR patients with
proximal anastomotic disruption (nZ 2) and recurrent AEF
or proximal anastomotic disruption in one patient, who was
not re-operated. There were three cases of RI (75%) in four
EAR surviving patients, with one recurrent AEF and two
recurrent AEFs or aortic stump blowout in two patients,
who were not re-operated. Finally, the two surviving
endovascular patients both died, one due to acute septic
occlusion of the endoprosthesis and the other due to
a recurrent AEF (Table 6). All of these patients with RI died:
three died per- or postoperatively and five were not re-
Table 5 Mortality and morbidity.
Mortality ISR N Z 25 (%) EAR N Z 9 (%) p value
30day 12 (48) 3 (33) 0.08
- procedure-relateda 14 (56) 5 (56) 1.0
Length of hospital stay (days) 21  6 20  8 0.09
Surgical complications:
- Acute limb ischemia 2 (8) 1 (11) 0.93
Graft occlusion 0 1 (11) e
Femoro-popliteal occlusion 2 (8) 0 e
- Wound complications 6 (24) 1 (11) 0.075
- Colonic infarction 1 (4) 2 (22) 0.056
- Duodenal leakage 0 1 (11) e
- Graft disruption
Femoral 1 (4) 0 e
Aortic 4 (16) 0 e
- Aortic leakage 0 1 (11) e
Medical complications
- Pulmonary 4 (16) 2 (22) 0.086
- Acute renal failure 2 (8) 1 (11) 0.93
- Colonic ischaemia 2 (8) 1 (11) 0.93
- Myocardial infarction 2 (8) 0 e
- Coagulopathy 1 (4) 1 (11) 0.07
ISR: In situ reconstruction; EAR: extra-anatomic reconstruction.
a Procedure-related mortality includes deaths after 30 days. Some patients died as a result of the operation later in the hospital
course.
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presented with shock while out of the hospital. Analysis of
RI rates for the various conduits for ISR was not possible in
this study because the size of the survival groups was too
small for statistical comparison: IGS (n Z 5), allograft
(n Z 3), autogenous vein (n Z 1) and Rifampin-bonded
grafts (n Z 2).
For all surviving patients, the rates of RI at 1 and 2 years
were, respectively, 24% and 41% (Fig. 1). Univariate analysis
did not detect any significant difference in the RI rate after
ISR or EAR (p Z 0.22) or between partial or total resection
of the infected graft (p Z 0.47) or between duodenal
defect treated by duodenorraphy or segmental duodenal
resection (p Z 0.19).
The main cause of late death (12 patients) was RI (eight
patients, 66%). The remaining four patients died of colic
neoplasm, myocardial infarcts, cerebral metastasis or
pulmonary embolism. Overall survival at 5 and 7 years was
11% (Fig. 2).Discussion
SAEF is the most serious form of AGI infection.710 The
operative mortality rate of 43% in our series remains
acceptable when compared with the results of other
contemporary series (range 13e57%) (Table 7). These rates
are probably attributable to the poor condition of these
patients at admission. The sole predictor of operative
mortality in our series was patient age (p Z 0.02). Preop-
erative shock approached, but not did reach, statisticalsignificance (p Z 0.06), a finding similar to the results of
other contemporary studies.1113
In our series, no difference was observed in operative
mortality between ISR and EAR. These results differ from
those of Bergqvist,4 who reported that the mortality rate
was lowest after staged EAR using an axillobifemoral bypass
as a first step, followed several days later by aortic graft
removal (Table 7). These patients certainly represent
a select group that was haemodynamically stable enough to
tolerate the delay associated with EAR and aortic ligature
with graft resection at a later date. This was not the case in
our study, where the majority of patients was unstable and
had to be treated emergently. In a recent meta-analysis,5
comparison of operative mortality after EAR and ISR for
AGI demonstrated a lower operative mortality after ISR
with Rifampin-bonded prostheses compared with EAR, and
challenged the status of EAR as the gold standard for SAEF.
The latter remains one of the most difficult vascular path-
ologic entities to treat, and optimal therapy is still very
much under discussion. Many surgeons,12,14 however, still
use a staged procedure with initial EAR, despite several
disadvantages compared with ISR. First, the intervention is
longer and midterm patency is not as good.9 Second, aortic
stump suturing is not always possible when the stump is
short, and the risk of thrombosis ascending towards the
renal arteries is compounded by the risk of aortic stump
blowout. Third, blood supply to the pelvis and the left colon
is usually compromised following EAR because it is impos-
sible to revascularise the internal iliac arteries and the
inferior mesenteric artery. In our series, the sole morbidity
that approached a statistically significant difference in
Table 6 Reinfection of the aortic graft reconstruction in 8 of 17 post-operative survival patients.
Extra-anatomic
reconstruction
(n Z 3)
Delay to
reinfection
(mo)
Reinfected graft Symptoms Re-operation for
RI: operative finding
and treatment
Results
1 24 PTFE Gastrointestinal
bleeding þ shock
Recurrent aorto-enteric
fistula: duodeno-
jejunostomy þ aortic
ligature
Operative
mortality
2 3 PTFE Hemorrhagic shock No e probable aortic
leakage or recurrent
aorto-enteric fistula
Death
3 6 PTFE Hemorrhagic shock No e probable aortic
leakage or recurrent
aorto-enteric fistula
Death
In situ aortic reconstruction (n Z 3)
1 3 Allograft Hemorrhagic shock Laparotomy: Aortic
disruption
Operative
mortality
2 10 Rifampin graft Hemorrhagic shock No e probable aortic
disruption or recurrent
aorto-enteric fistula
Death
3 15 IGS Hemorrhagic shock Thoracic clamp þ EAR:
aortic disruption
Operative
mortality
Endovascular repair (n Z 2)
1 6 Zenith Cook Acute lower limb
ischemia, pelvic
ischemia
No e septic occlusion of
the endoprosthesis
Death
2 8 Zenith Cook Gastrointestinal
bleeding þ shock
No e probable recurrent
aorto-enteric fistula
Death
RI: reinfection; IGS: Inter Gard Silver e EAR: extra-anatomic reconstruction. PTFE: Poly-tetra fluoro-ethylene.
Results of Secondary Aortoenteric Fistulae 755favour of ISR was colonic infarction. The University Texas-
Houston6 initiated ISR for SAEF, and more and more
surgeons have adopted the broadened indications for
ISR.5,710,1517 It was also the case, in this series, where the
first ISR was made in 2000 with progressively more and moreFigure 1 Freedom from recurrent infection.ISRs being used as the study progressed. Perhaps the most
difficult aspect of managing SAEF is selection of the
appropriate treatment for any given patient. A patient in
a poor but stable condition requires a detailed work-up that
may include blood transfusion, antibiotics and correction of
malnutrition to maximise the possibilities of a successful
outcome. In situ autogenous graft replacement may be
most appropriate for younger patients with a longer life
expectancy and, thus, a higher risk of long-term failure. InFigure 2 Actuarial survival rate.
Table 7 Treatment of secondary aorto-enteric fistula. Results of contemporary studies.
Authors (year) N (follow-up) Emergency
intervention (%)
Operative
mortality (%)
Recurrent
infection (%)
Extra-anatomic
reconstruction
Kuestner12 (1995) 31 (52) 13 27 24
Menawat13 (1997) 52 (39) 37 23 45
Yeager9 (1999) 16 (41) e 19 NA
Dorigo14 (2003) 30 (10) 20 26 10
Sierra15 (2003) 7 () e 44 20
Armstrong10 (2005) 25 (51) 17 24 13
Most stable patients
treated
Berqvist2 (2009) 163 () e Simultaneous
51 Staged 31
NA
This series 9 (41) 33 44 75
In situ reconstruction Menawat12 (1997) 10 (39) 37 30 10
Lavigne15 (2003) 4 () NA 50 20
Kieffer6 (2004) 24 () NA 19 NA
Oderich7 (2006) 30 (40) NA 13 2
Batt5 (2008) 7 (32) 43 57 14
Berqvist2 (2009) 96 () e 47 NA
Ali8 (2009) 26 (32) 0 31 30
This series 25 (41) 54 48 27
NA: not available.
756 M. Batt et al.situ prosthetic graft replacement may be better in emer-
gent cases and in older and sicker patients, due to the ease
of use, availability and shorter operative time. Bowel
surgery is an integral part of SAEF. Particular attention must
be paid to duodenal repair. Direct intestinal closure can be
used if the defect is small. If the defect is longer,
a segmental resection of the duodenum should be done to
prevent leakage and RI.
In patients with severe haemodynamic shock, endovas-
cular repair provides time to treat shock, local and systemic
infection and co-morbidity.18 Endovascular repair was used
for the first time in this series in 2006. The two surviving
patients in our series, who underwent endovascular repair,
died with recurrence of a fistula in one case and acute septic
thrombosis of the endoprosthesis in the other following
cessation of antibiotic treatment because of presumed GI
intolerance. Antibiotic and antifungal treatment in this
endovascular patient group is of the utmost importance
because infectedprostheticmaterial is not resected, and the
risk of RI justifies open repair as soon as the risk factors are
reduced to an acceptable level.
The risk of RI continues with the length of follow-up. The
rate of RI at 1 and 2 years increased from 24% to 41% in our
series (Fig. 1), and RI was the main cause of late death.
Instinct suggests removal of an infected graft in its entirety
rather than a partial excision to prevent RI. However, poor
patient condition and operative problems, including
collateral arteries and limb salvage, may dictate otherwise,
depending on the macroscopic appearance of the graft.
Miller19 demonstrated that when the remainder of the
prosthesis is well encapsulated, it can be safety left in
place. In our series, 79% of the patients had total graft
resection and 19% had limited resection. In multivariate
analysis, limited resection was not correlated with RI. In
elective cases, the use of pre-operative radionuclidepositron emission tomography (PET) scan could, in some
cases, define the extension of infection and allow better
planning for the procedure. Furthermore, this baseline PET
scan image helped to define the duration of antibiotic
therapy. These scans are, however, currently expensive,
not widely available and the experience in vascular disease
very limited.20 There is no consensus in the literature
concerning the length of oral antibiotic therapy.811 Life-
long oral antibiotic therapy has several limitations: devel-
opment of resistance, intolerance and inobservance. The
continuing risk of RI warrants surveillance with lifelong CT
scans. A potential benefit of EAR is that revascularisation is
at a distance from the site of infection, and RI might thus
be expected to be minimal. This was not borne out in our
study or in other contemporary series (Table 6), where no
difference was seen in the rates of RI after ISR or EAR.
Various conduits for ISR have been reported to prevent
RI. Autogenous veins5,10,15 and cryopreserved allografts8
are associated with the lowest rates of RI. However, in an
emergency setting, the operative time required to obtain
the vein and the availability of allografts are major factors
limiting their use. Conversely, silver-coated or Rifampin-
bonded prostheses are readily available in various types
and sizes. Nevertheless, questions remain concerning the
resistance to infection of prosthetic grafts, as only a few
studies have investigated this issue with rigour.9,16,21,22Conclusion
SAEF is one of the most challenging pathological entities
encountered in vascular surgery. In our series, the results of
EAR do not appear to be superior to ISR, and this raises the
question ofwhether extra-anatomic bypass should remain the
gold standard for treatment of SAEF. The risk of RI must never
Results of Secondary Aortoenteric Fistulae 757be forgotten, especially with longer follow-up. Lifelong
surveillance is mandatory. Endovascular sealing of SAEF is
apromising technique,and shouldbeconsideredas abridge to
open repair because the danger of RI remains high.
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